Log In
BCIQ
Print this Print this
 

ProCvax (Prophylactic HCV vaccine)

Also known as: formerly PerCvax

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionVaccine composed of replication-defective adenovirus vector (chimpanzee-derived serotype 3 (AdCh3) and MVA that encode the non-structural (NS) proteins NS3-5
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationHepatitis C virus (HCV)
Indication DetailsPrevent hepatitis C virus (HCV) infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$323.0M

$323.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/29/2013

$323.0M

$323.0M

0

Get a free BioCentury trial today